EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 182 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2017. The put-call ratio across all filers is 2.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $3,336,000 | +14.2% | 63,813 | +5.5% | 0.04% | +16.2% |
| Q2 2019 | $2,921,000 | -21.0% | 60,460 | -17.4% | 0.04% | -22.9% |
| Q1 2019 | $3,696,000 | -16.7% | 73,158 | -2.3% | 0.05% | -28.4% |
| Q4 2018 | $4,438,000 | -18.9% | 74,873 | -9.9% | 0.07% | -5.6% |
| Q3 2018 | $5,472,000 | +23.2% | 83,121 | -5.5% | 0.07% | +16.4% |
| Q2 2018 | $4,442,000 | -0.4% | 87,982 | +3.8% | 0.06% | -3.2% |
| Q1 2018 | $4,461,000 | +55.9% | 84,731 | +37.6% | 0.06% | +50.0% |
| Q4 2017 | $2,861,000 | +21.8% | 61,563 | +6.0% | 0.04% | +16.7% |
| Q3 2017 | $2,348,000 | +33.0% | 58,056 | +11.5% | 0.04% | +12.5% |
| Q2 2017 | $1,766,000 | +28.2% | 52,080 | +9.8% | 0.03% | +23.1% |
| Q1 2017 | $1,378,000 | +152.4% | 47,448 | +185.4% | 0.03% | +136.4% |
| Q4 2016 | $546,000 | +154.0% | 16,624 | +144.3% | 0.01% | +120.0% |
| Q3 2016 | $215,000 | – | 6,805 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 25,250 | $784,000 | 2.30% |
| Global Alpha Capital Management Ltd. | 418,030 | $12,976,000 | 1.40% |
| AIMZ Investment Advisors, LLC | 70,588 | $2,191,000 | 1.05% |
| PALISADE CAPITAL MANAGEMENT, LP | 566,080 | $17,571,000 | 0.48% |
| RICE HALL JAMES & ASSOCIATES, LLC | 261,533 | $8,118,000 | 0.39% |
| EARNEST PARTNERS LLC | 1,844,621 | $57,257,000 | 0.38% |
| SummerHaven Investment Management, LLC | 14,476 | $449,000 | 0.30% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,085,874 | $33,706,000 | 0.26% |
| Ridgewood Investments LLC | 10,004 | $311,000 | 0.24% |
| DUALITY ADVISERS, LP | 65,650 | $2,038,000 | 0.20% |